Yes, in Japan, the Designated Marketing Authorization Holder (DMAH) is responsible for ensuring compliance with Good Manufacturing Practice (GMP) and Good Vigilance Practice (GVP). The DMAH oversees the quality, safety, and efficacy of pharmaceutical products, ensuring adherence to regulatory standards throughout the product lifecycle, including post-marketing surveillance.
